News

EPI-743, an orally absorbed small molecule that readily crosses into the central nervous system, works by targeting an enzyme NADPH quinone oxidoreductase 1 (NQO1). EPI-743 is in phase

As per the agreement, Neuralstem will allow SPI to market the development and licensing rights to its neurogenic compound NSI-189. NSI-189, indicated as a treatment for major depression

The awarded money will be used by OPKO’s wholly-owned Mexican subsidiary Exakta-OPKO to enhance the development of research projects in ophthalmology, infectious disease and oncology. OPKO chairman and

Memary, an N-methyl-D-aspartate (NMDA) receptor antagonist, is the generic version of Memantine Hydrochloride, which was licensed from Merz Pharmaceuticals. Daiichi Sankyo has obtained the Japanese approval to manufacture

Watson‘s Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.09mg/0.02mg are the generic version of Lybrel Tablets of Pfizer. Lybrel is indicated for the prevention of pregnancy in women who

The new solution extends the Monaco On Demand Reporting and Analytics platform with a visualization tool that provides real-time visibility into large sales and financial performance data sets.

Matrix‘s Donepezil Hydrochloride (HCl) Tablets, 5mg and 10mg are the generic version of Aricept Tablets of Eisai. Aricept is a prescription medicine which is indicated for the treatment

The expansion will add 1858m² of space and associated equipment and support cell line construction, upstream and downstream process development, and a range of analytical services. The expanded

VEGF Trap-Eye, a human fusion protein consisting of portions of VEGF receptors 1 and 2, binds all forms of VEGF-A along with the related Placental Growth Factor (PlGF).